Cracking the Code: Revolutionizing Mesothelioma Staging
A group of researchers from the International Association for the Study of Lung Cancer (IASLC) teamed up to help us…
Breakthrough in Mesothelioma Treatment: Cellectis’ Promising CAR-T Therapy
Mesothelioma is a challenging cancer with limited treatment options. Yet, recent advancements in CAR-T therapy are bringing new hope to…
How Inflammation, Stress, and Signaling Shape Mesothelioma’s Growth
Scientists are looking at how long-term inflammation, cell stress, and messed-up cell signaling help mesothelioma cancer cells grow and spread.…
Mesothelioma Treatment Roadmap: Connecting Chemotherapy Response and Surgical Outcomes
Mesothelioma patients who do not respond well to chemotherapy before surgery are likely to have poor outcomes after the procedure.…
Unveiling the Mesothelioma Risk Posed by Exposure to Asbestos
Asbestos is a toxic mineral found naturally throughout the world. Exposure to asbestos can cause people to develop mesothelioma, which…
Empowering Mesothelioma Patients with Patient-Reported Symptom Monitoring
New data shows that patient-reported symptom monitoring improves the quality of life in lung cancer patients. The study was published…
New Hope for Mesothelioma Patients in Intensive Care
In the fight against mesothelioma, there’s new and hopeful data that might help patients who end up in the intensive…
How Photodynamic Therapy is Changing the Game for Mesothelioma Patients
When it comes to treating a tough cancer like malignant pleural mesothelioma, doctors use many different methods. One important way…
Decoding the BAP1 Gene: How Family History Can Influence Tumor Risks
A group of doctors and scientists from Europe and the UK got together to create guidelines to help people with…
Breaking Down the Costs: Immunotherapy as Mesothelioma Treatment
It is not a secret that cancer treatments can be expensive. Researchers from Switzerland looked at whether immunotherapy is worth…